Gene · 360
AQP3: aquaporin 3 (Gill blood group)
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AQP3: aquaporin 3 (Gill blood group). Genes, record 360. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/360
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92482 | Aquaporin-3 | 292 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents60
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37755 | Q92482 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 200 | Q92482 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 429 | Q92482 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 429 | Q92482 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 5952 | Q92482 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 200 | Q92482 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 5952 | Q92482 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 3168 | Q92482 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 108923 | Q92482 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 678 | Q92482 | Espacenet |
1 to 10 of 60
See all 60 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants937
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AQP3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 4 | 2025 |
| ZIAHL001285 | Solute And Water Transport In Renal Epithelia | 4 | 2025 |
| IK6BX005691 | BLRD Research Career Scientist Award Application | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| R01GM079465 | Chemical Probes to Study Copper Biology | 3 | 2025 |
| R35HL145242 | Defining and Controlling Airway Disease | 3 | 2025 |
| I01BX000930 | Oxyntic Atrophy and Novel Gastric Lineages. | 2 | 2025 |
| P20GM103423 | The Maine Biomedical Research Network (INBRE) | 2 | 2025 |
1 to 10 of 937Source NIH's project files
See all 937 nih grantsPapers2,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aquaporin-3 amplifies arsenite genotoxicity as a dose-dependent gene-by-environment interaction in human cells. | bioRxiv | 2026 | 42818246 | PubTator, text mining | PubMed |
| Aquaporin-9 and aquaporin-10 but not aquaporin-3 confer susceptibility to dimethylarsinic acid genotoxicity in human cells. | bioRxiv | 2026 | 42818007 | PubTator, text mining | PubMed |
| Pedunculoside alleviates cheilitis-like inflammation by suppressing the TLR3/TRIF/NF-κB signaling. | Int Immunopharmacol | 2026 | 42805066 | PubTator, text mining | PubMed |
| Succinate Dehydrogenase Subunit D as a Redox-Responsive Mitochondrial Component Linked to Aquaporin-Associated Hydrogen Peroxide Signaling in Glioblastoma Cells. | Antioxidants (Basel) | 2026 | 42792164 | PubTator, text mining | PubMed |
| Aquaporin 3 Promoter Polymorphisms Reduce Gene Expression and Associate Altered Autophagy-Related Gene Signatures With Atopic Dermatitis Susceptibility. | Exp Dermatol | 2026 | 42744597 | PubTator, text mining | PubMed |
| Royal jelly-loaded sodium alginate nanoparticles fabricated by Ca2+ crosslinking: Preparation, characterization and bioactivity evaluation. | Int J Biol Macromol | 2026 | 42722260 | PubTator, text mining | PubMed |
| Effects of minerals and xylitol solution on human nasal epithelium: Water channels upregulation and potential anti-inflammatory properties. | Braz J Otorhinolaryngol | 2026 | 42685398 | PubTator, text mining | PubMed |
| Influence of Oral Collagen Peptides on Skin Biophysical Properties in Humans: A Narrative Review. | Clin Cosmet Investig Dermatol | 2026 | 42643905 | PubTator, text mining | PubMed |
| Aquaporin 5 and Nuclear Factor Erythroid 2-Related Factor 2 Upregulation in Tumor and Stroma Is Associated with Poor Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. | Med Princ Pract | 2026 | 42574300 | PubTator, text mining | PubMed |
| Transcriptome profiling of ocular surface ectoderm derived from embryonic stem cells, and identification of CACNG6 and AQP3 as its surface markers. | Int J Ophthalmol | 2026 | 42523845 | PubTator, text mining | PubMed |
1 to 10 of 2,911
See all 2,911 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/360
GET https://conductscience.org/api/genes/v1/360/patents?page=2